HopeStage
Back to all studies
Enrolling By InvitationNCT06931236

Clinical Efficacy and Mechanism of rTMS Based on dlPFC in the Intervention of Generalized Anxiety Disorder With Insomnia

Device studyAges 15–65China
The study in practice

Understand this study

Who could participate?

Listed age limits: 15 years to 65 years.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: August 1, 2024
Recruitment status
Enrolling By Invitation
Enrollment listed in the registry
30
Sponsor
Yanghua Tian
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
China
Age range
From 15 Years to 65 Years
Official registry ID
NCT06931236
Official title
Show the full official title

Clinical Efficacy and Mechanism of Repetitive Transcranial Magnetic Stimulation Based on dlPFC in the Intervention of Generalized Anxiety Disorder With Insomnia: An Open-label Study

Recruitment & locations

By invitation

Hefei

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yanghua Tian.

Who can participate?

Listed age limits: 15 years to 65 years.

Is this study still recruiting?

The registry lists this study as enrolling by invitation.

Want to explore more studies?

Explore studies